Bio

Dr Ordoñez joined Noble in 2016. He has sixteen years of experience in various segments of the healthcare capital markets. Recently, he was President and co-founder of Ciclofilin Pharmaceuticals, a San Diego based-biotechnology company, which was sold to ContraVir Pharmaceuticals. During his career, he has worked on various roles in Buy-side and Sell-Side Institutions, including Difference Capital Financial Inc., and GMP Securities Inc. in Canada. Dr Ordoñez has advised and helped raise funds for North American companies in drug development, medical device, specialty pharma and healthcare services areas. He is a Medical Doctor and obtained a Ph.D in Experimental Medicine and Biochemistry from McGill University in Montreal, Canada. He also completed post-doctoral training at the Karolinska Institute/Hospital in Stockholm, Sweden.